Yang_2021_Cardiovasc.Drugs.Ther_35_467

Reference

Title : Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the Prime Time of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching? - Yang_2021_Cardiovasc.Drugs.Ther_35_467
Author(s) : Yang J , Li X , Xu D
Ref : Cardiovasc Drugs Ther , 35 :467 , 2021
Abstract : Yang_2021_Cardiovasc.Drugs.Ther_35_467
ESTHER : Yang_2021_Cardiovasc.Drugs.Ther_35_467
PubMedSearch : Yang_2021_Cardiovasc.Drugs.Ther_35_467
PubMedID: 32500296

Related information

Citations formats

Yang J, Li X, Xu D (2021)
Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the Prime Time of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?
Cardiovasc Drugs Ther 35 :467

Yang J, Li X, Xu D (2021)
Cardiovasc Drugs Ther 35 :467